GaldermaReceivesU.S.FDAApprovalforRestylaneLyftfortheEnhancementoftheChinProfile
===2025/11/5 21:22:08===
Data on file. MA-34483. Study Report. Galderma Laboratories, L.P., 2021.
Di Gregorio C, Avelar L, Lam S, et al. 25+ years of experience with the Restylane portfolio of injectable HA fillers for facial aesthetic treatment. E-poster presented at AMWC; March 27-29, 2024; Monaco.
Nikolis A, Enright KM, Lazarova D, et al. The role of clinical examination in midface volume correction using hyaluronic acid fillers: should patients be stratified by skin thickness?Aesthet Surg J Open Forum. 2020; 2(1):1–12.
Galderma. Data on file. Subject satisfaction (GAIS) – NASHA and OBT Fillers. 2021.
Kablik J, Monheit GD, Yu LP, et al. Comparative physical properties of HA dermal fillers.Dermatol Surg.2009; 35, 302–312.
Bromée T, Öhrlund Å, Winlöf P, et al. A new hyaluronic acid injectable, HASHA, sets new G-prime standards. Abstract presented at AMWC 2025; Mar 27-29, 2025; Monaco.
N
=*=*=*=*=*=
当前为第11/13页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页